单次饮用绿茶对健康志愿者纳多洛尔药代动力学的影响
本研究为随机三阶段交叉试验,11名健康志愿者分别在同服或提前1小时饮用绿茶后口服纳多洛尔,与用水送服对照。结果显示同服绿茶使纳多洛尔AUC0-48几何均值比降至0.371(90%CI 0.303-0.439),提前1小时饮用亦降至0.536(90%CI 0.406-0.665),提示单次绿茶可显著降低纳多洛尔血浆浓度且效应至少持续1小时。
要点
- 同服绿茶使纳多洛尔AUC0-48几何均值比降至0.371,显著降低生物利用度。
- 提前1小时饮用绿茶仍使AUC0-48几何均值比降至0.536。
- 达峰时间与肾清除率在各组间无差异。
核心结论
- 单次同服绿茶可大幅降低纳多洛尔血浆浓度。
- 饮用一杯绿茶后至少1小时内纳多洛尔生物利用度降低的效应仍持续。
研究设计与样本
- 随机三阶段交叉研究,纳入11名健康志愿者。
- 受试者分别接受纳多洛尔与绿茶同服、提前1小时饮用绿茶后服用纳多洛尔、或用水150mL送服纳多洛尔。
主要发现
- 同服绿茶时纳多洛尔AUC0-48几何均值比为0.371(90%CI 0.303-0.439)。
- 提前1小时饮用绿茶时纳多洛尔AUC0-48几何均值比为0.536(90%CI 0.406-0.665)。
- 各组间达峰时间与肾清除率无差异。
临床怎么用
- 临床应提醒服用纳多洛尔的患者避免同服或近期饮用绿茶,以免血药浓度下降影响疗效。
局限性
- 仅纳入11名健康志愿者,样本量小。
- 仅评估单次绿茶摄入的短期影响,未涉及长期饮用或不同茶类。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: The aim of this study was to investigate the effects of a single green tea (GT), administered concomitantly or 1 hour before nadolol intake on nadolol pharmacokinetics. METHODS: In a randomized 3-phase crossover study, 11 healthy volunteers received an oral administration of nadolol with, or 1 hour after preingestion of brewed GT, or with water in a volume of 150 mL. RESULTS: Geometric mean ratio with 90% confidence interval for nadolol AUC0-48 was 0.371 (0.303-0.439) with concomitant GT. In addition, ingestion of GT 1 hour before nadolol administration resulted in a significant reduction of nadolol AUC0-48 with geometric mean ratio of 0.536 (0.406-0.665). There were no differences in time to maximal plasma concentration and renal clearance of nadolol among groups. CONCLUSION: These results suggest that single concomitant ingestion of GT substantially decreases plasma concentrations of nadolol. Moreover, the reduction in nadolol bioavailability could persist for at least 1 hour after drinking a cup of GT.
引用
- Misaka S, Abe O, Ono T, et al. Effects of single green tea ingestion on pharmacokinetics of nadolol in healthy volunteers. Br J Clin Pharmacol. 2020. PMID: 32320490. doi:10.1111/bcp.14315
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。